Navigation Links
Align Technology Announces Second Quarter Fiscal 2009 Results
Date:7/23/2009

------- Operating expenses: Sales and marketing 29,108 32,464 56,962 60,523 General and administrative 16,539 16,322 30,007 31,510 Research and development 5,669 7,001 10,860 14,296 Restructuring 409 - 1,319 - --- --- ----- --- Total operating expenses 51,725 55,787 99,148 106,329 ------ ------ ------ ------- Profit from operations 6,253 3,872 11,537 8,498 Interest and other income, net 557 443 705 1,409 --- --- --- ----- Profit before income taxes 6,810 4,315 12,242 9,907 Provision for income taxes (2,265) (285) (5,061) (573) ------ ---- ------ ---- Net profit $4,545 $4,030 $7,181 $9,334 ====== ====== ====== ====== Net profit per share - basic $0.07 $0.06 $0.11 $0.14 ===== ===== ===== ===== - diluted $0.07 $0.06 $0.11 $0.13 ===== ===== ===== ===== Shares used in computing net profit per share - basic 66,285 68,581 66,135 68,817 ====== ====== ====== ====== - diluted 67,373 69,916 66,941 70,478 ====== ====== ====== ====== ALIGN TECHNOLOGY, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in th
'/>"/>
SOURCE Align Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Align Technology Provides Update on Patent Litigation with Ormco Corporation
2. Orthocare Innovations Receives Prestigious R&D 100 Award for Computerized Prosthesis Alignment System
3. David Nagel Joins Align Technology Board of Directors
4. Health Information Technology and Health Care Reform Must Be Well-Aligned to Improve Health and Lower Costs
5. Align Technology to Announce Second Quarter Fiscal 2009 Results on July 23, 2009
6. Jury Renders Verdict for Ormco - Aligns Invisalign(R) Product Infringes Ormco Patent
7. Align Technology Announces Jury Verdict in Patent Litigation With Ormco Corporation
8. Cell Protein Could Help Spur Malignancy
9. GS1 Canada and GHX Align to Make Canadas Healthcare Supply Chain More Efficient and Effective
10. Align Technology Executive to Present at Upcoming Financial Conference
11. Many Childhood Cancer Survivors Not Checking for Second Malignancies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswire...tatement after the Senate voted to begin full deba...(Logo: http://www.newscom.com/cgi-bin/prnh/200805...er historic step on the road to enacting health in...hurdle, senators will now have an opportunity to d...
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswir...to eliminate onchocerciasis (river blindness) in t...ce of the disease in recent years, as evidenced by...ring mass drug administration in six endemic count...ual meeting of the American Society of Tropical Me...
(Date:11/21/2009)... NH based medical credentiali... in its industry to form a partnerhsip with Amerin.... This partnership will help to transform quality... (Vocus) November 21, 2009 -- ISG Grou...nnounced a new agreement with Amerinet Inc., a lea...
(Date:11/21/2009)... Eric J. Hall, president and ...ion of America (AFA) issued the following statemen...detection as part of the new annual wellness for M...ion and Affordable Care Act" that was introdu...k, NY (PRWEB) November 21, 2009 -- Eric J. Hall, p...
(Date:11/20/2009)... , Pioneering Neurologist Closer to Understand...v. 20 Dr. Jeremy Schmah...hool and neurologist at the Massachusetts General ...ented his laboratory,s research on the new field o... MINDlink Foundation. ,, Dr. Schmahmann is an a...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...cer of the voice box (larynx) who receive radiothe...ding to new data presented at the European Society...trition (Zurich, 20-21 March 2009). , Larynx canc...cer is greatly increased by tobacco smoking and al...
...candinavian Prostate Cancer Group Study 4 (SPCG-4)...tate cancer survival compared with watchful waitin... 24th Annual EAU Congress in Stockholm, Sweden the...uded men whose prostate cancer was not detected by...
...ht has been identified for decades as a significan...ientists have found that the absence of gravity is...tion to lose up to 10 times more bone mass in key ...itions through the use of long-duration bedrest, r...
...as Kaiser Permanente, City of Pasadena and Race Or...s Participants , , PASADENA, Calif., March 20 Th...s and intermittent showers for this Sunday,s Inaug... City of Pasadena and Pasadena Forward prepared fo...
...gis Corporation, a leading international manufactu...g products and specialty packaging solutions, will... 2008 fourth quarter and full year results on Frid...onal: 617-614-3669; Participant Passcode: 28484117...
...otentially harmful products , , FRIDAY, M...ng the millions accidentally exposed to a harmful... just during National Poison Prevention Week but a...han half of the 2 million poison exposure incident...
Other Medicine News:Health News:SPCG-4 trial: Update on watchful waiting versus radical prostatectomy 2Health News:University of Washington scientists one step closer to stopping bone loss during spaceflight 2Health News:Kaiser Permanente Pasadena Marathon is Ready and Set to Go Sunday 2Health News:Kaiser Permanente Pasadena Marathon is Ready and Set to Go Sunday 3
(Date:11/19/2009)...PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals,... of a public offering of 5,000,000 shares of its c... proceeds of $48.75 million. All of the shares ar...ve shelf registration statement previously filed w...yst has also granted the underwriters a 30-day opt...
(Date:11/19/2009)...RNewswire-FirstCall/ -- In a series of new initiat...orporation (Nasdaq: HSKA ) ("Heska" or the "Compa...roved website. The upgraded site is the result of...g to align the site with the company,s new brand i...p://www.newscom.com/cgi-bin/prnh/20000622/HESKALOG...
(Date:11/19/2009)...9 Alexza Pharmaceuticals...orporate presentation will be webcast live during ...ce on Wednesday, December 2, 2009 at 9:00 a.m. Eas...The New York Palace Hotel in New York and will be ...CEO. ,, To access the live presentation via t...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 5173 1Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 5173 2Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 5173 3InVitria Launches Zap CHO to Enhance CHO Cell Culture Performance 58715 1InVitria Launches Zap CHO to Enhance CHO Cell Culture Performance 58715 2InVitria Launches Zap CHO to Enhance CHO Cell Culture Performance 58715 3Pharmasset to Present at JMP Securities Healthcare Conference 58712 1Pharmasset to Present at JMP Securities Healthcare Conference 58712 2Pharmasset to Present at JMP Securities Healthcare Conference 58712 3
...ficant Results Achieved at Two Dose Levels with No...arch 2 Nektar Therapeutics (Nasdaq: NKTR ) anno...2 double-blind, randomized, placebo-controlled stu...stipation (OIC). NKTR-118, a peripheral opioid an...ug to treat OIC, the most common and debilitating ...
...issueGene, Inc. announced today that its South Kor...S) has received regulatory allowance from the Kore...a Phase IIa clinical trial of TissueGene-C (TG-C) .... TG-C has been developed for the localized deliv... in order to induce the regeneration of cartilage....
Other Medicine Technology:Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 2Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 3Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 4Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 5Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 6TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee 2
...ble pre-fabricated orthosis is designed for the ma...hyseal fractures. The lightweight anatomical desig...ue compression for optimal control of humeral segm...der and elbow joints. In addition this brace featu...
Humeral Stabilizing System (HSS)
Functional Arm Brace
.... Control the ankle. This simple concept is the co...hnology. When you lock the heel with our patent-pe... stability and comfort your patient will experienc...wraps around the heel and supports the posterior a...
Medicine Products: